Electroencephalography Equipment Companies 2025 | US Tariff Impact | Regional Insights | Company Profiles

Electroencephalography (EEG) equipment refers to medical devices used to record electrical activity in the brain. EEG monitoring is crucial for diagnosing neurological disorders such as epilepsy, sleep disorders, brain tumors, encephalopathies, and assessing brain activity in coma patients.

EEG equipment typically includes electrodes, amplifiers, recording devices, and sophisticated signal analysis software. The technology has evolved from traditional analog recordings to today’s advanced digital, wireless, and portable systems that provide greater accuracy, patient comfort, and real-time brain activity visualization.

Key Industry Facts:

• As of 2025, over 34 million EEG procedures are conducted annually worldwide.
• EEG systems are standard in 92% of neurology departments across developed economies.
• Portable EEG device adoption has increased by 17.3% over the past two years, driven by demand for ambulatory and home-based monitoring.

With increasing neurological disease prevalence and technological advancements, EEG equipment has transitioned from a niche diagnostic tool to a mainstream pillar in clinical neuroscience and critical care units.

USA Growing Electroencephalography Equipment Market

The United States leads global EEG equipment consumption due to its sophisticated healthcare infrastructure, strong neurological research environment, and increasing burden of neurological diseases.

Key U.S. Market Figures:

• USA EEG Equipment Market Size (2025): Estimated at $820 million across hospitals, research institutions, and outpatient centers.
• Hospital Adoption Rate: Approximately 88% of U.S. hospitals with 100+ beds use EEG monitoring as part of standard diagnostic protocols.
• Ambulatory EEG Expansion: Ambulatory and home-based EEG monitoring services expanded by 13.6% year-over-year in 2025.
• Clinical Research Growth: U.S. clinical research institutions contributed to 41% of global EEG-related research publications in 2025, reflecting deep scientific investment.
• Technological Innovation: Wireless EEG headsets accounted for 24% of new device purchases in the U.S. neurology market.

How Big is the Electroencephalography Equipment Industry in 2025?

Globally, the EEG equipment market is witnessing steady expansion driven by neurological disease burden, healthcare infrastructure modernization, and demand for early diagnosis tools.

Global Industry Facts:

• Global EEG Equipment Market Size (2025): Estimated at $1.9 billion across clinical, research, and ambulatory care settings.
• Annual Units Shipped: Over 29,000 EEG systems shipped globally in 2025, reflecting a 5.7% year-on-year growth.
• Regional Split:
  • North America holds 42% share.
  • Europe accounts for 29% share.
  • Asia-Pacific shows rapid growth with 22% share.
• Portable EEG Segment Growth: Portable and wireless EEG systems now represent 31% of global new installations.
• Healthcare Integration: Approximately 72% of new hospital neurology units worldwide included EEG monitoring systems by default in 2025.

The surge in telemedicine, home-based neurological monitoring, and AI integration is redefining traditional EEG diagnostics, creating a dynamic and innovation-driven market environment.

US Tariff Impact – A Business Transformation Catalyst

The 2025 U.S. tariffs targeting medical electronics, sensors, and semiconductor components had a significant impact on the electroencephalography (EEG) equipment market. These tariffs disrupted supply chains, raised equipment costs, and forced both manufacturers and healthcare providers to reconsider sourcing and procurement strategies.

Key Tariff Impact Facts:

• Equipment Cost Increase:
  The average price of EEG systems rose by 5.4% in 2025 compared to 2024, primarily due to increased costs for electronic components and signal processing units.
• Delivery Delays:
  Tariff-induced component shortages led to an average 17-day extension in equipment delivery timelines across North America.
• Manufacturing Shifts:
  About 26% of EEG device manufacturers initiated or accelerated plans to shift component sourcing away from tariff-affected countries to mitigate supply chain risks.
• Research Procurement Challenges:
  U.S.-based clinical research facilities reported a 7.1% increase in procurement costs for new EEG systems, influencing grant budgeting and project timelines.
• Service and Maintenance Cost Inflation:
  Maintenance contract prices for EEG systems rose by 4.8% as part suppliers adjusted to higher input costs.

C-Suite Angle: Electroencephalography Equipment – Why It Matters

EEG equipment has emerged as a boardroom-level strategic asset for hospitals, research institutions, and medical device manufacturers. It plays a critical role in patient care quality, operational excellence, and clinical research leadership.

Strategic Business Metrics:

• Operational Efficiency Impact:
  EEG systems capable of wireless monitoring improved patient throughput in neurology departments by 16.3%, optimizing bed management and clinical workflow.
• Research Competitiveness:
  Institutions with state-of-the-art EEG labs produced 29% more peer-reviewed neuroscience publications than those with outdated diagnostic infrastructure.
• Financial Payback:
  Hospitals integrating EEG systems with EMR (Electronic Medical Record) systems reported an average operational cost saving of 3.8% annually due to better diagnostic turnaround times.
• Patient Satisfaction:
  Facilities using modern EEG systems with wireless capabilities noted a 12.7% higher patient satisfaction rating in neurology departments.
• Market Differentiation:
  Private healthcare providers offering cutting-edge neurological diagnostics with advanced EEG tools achieved 18% higher patient retention rates compared to competitors without EEG modernization.

C-Suite Insight:
EEG technology investments have moved beyond technical upgrades — they now directly influence clinical quality ratings, brand positioning, and financial sustainability.

Electroencephalography Equipment Market – Why It Matters

The significance of EEG equipment in 2025 extends well beyond neurology; it anchors multidisciplinary clinical diagnostics, critical care monitoring, and cutting-edge brain research.

Clinical and Market Importance Facts:

• Neurological Disease Burden:
  Over 50 million people worldwide suffer from epilepsy alone, a key area where EEG is the frontline diagnostic tool.
• Critical Care Usage:
  68% of intensive care units (ICUs) in developed markets use continuous EEG (cEEG) monitoring for patients with traumatic brain injuries, seizures, and stroke.
• Sleep Disorder Diagnostics:
  EEG systems contribute to 86% of sleep study evaluations, linking neurology with pulmonology and psychiatry.
• Brain-Computer Interface (BCI) Research:
  EEG equipment underpins approximately 60% of active BCI research projects globally, creating a fast-growing intersection of healthcare and technology sectors.
• AI-Driven Diagnostic Expansion:
  AI-integrated EEG analysis systems expanded by 9.4% in deployment during 2025, offering faster interpretation and predictive insights for clinicians.

What to Expect: Electroencephalography Equipment Market Outlook in a Tariff-Shaped Future

The global electroencephalography (EEG) equipment market is adapting to new economic and technological realities shaped by tariffs, supply chain adjustments, and healthcare system evolution. The future outlook indicates resilience, regional expansion, and technological acceleration.

Market Outlook and Key Figures:

• Continued Market Growth:
  Despite tariff-related price pressures, the EEG equipment market is expected to grow by 5.9% in unit installations globally from 2025 to 2026, driven by healthcare demand for neurological diagnostics.
• Portable and Wireless EEG Expansion:
  Portable EEG systems are projected to account for 34% of all new EEG equipment sales by the end of 2026, up from 31% in 2025.
• Regional Growth Opportunities:
  • Asia-Pacific EEG equipment installations are forecasted to increase by 8.2% year-over-year in 2025–2026, led by China and India.
  • Latin America expected to see 4.6% EEG equipment installation growth, driven by private hospital investment.
• Procurement Model Evolution:
  Subscription-based EEG equipment leasing ("EEG-as-a-Service") is projected to capture 12.7% of new commercial sales volume in 2026, up from 9.5% in 2025.
• Tele-EEG Integration:
  Adoption of cloud-connected EEG devices capable of remote diagnostics is expected to rise by 13.1% annually through 2027, driven by telemedicine expansion.

Key Future Shifts:

• Hospitals are prioritizing flexible, modular EEG systems that can be upgraded as technology evolves.
• Research institutions are accelerating investment into dense array EEG and high-definition EEG (hdEEG) platforms for advanced brain research.
• Portable EEG and ambulatory monitoring services will expand healthcare access into rural and underserved regions globally.

US Tariff Impact: Policy Shocks Driving Industry-Wide Reevaluation

The 2025 tariff shocks triggered a broad strategic reevaluation across the EEG equipment supply chain, reshaping how companies source components, manufacture devices, and engage healthcare customers.

Reevaluation Dynamics with Figures:

• Supply Chain Risk Management:
  About 74% of EEG equipment manufacturers have diversified their supply chains by incorporating secondary or tertiary component sourcing partners post-2025.
• Inventory Strategy Shifts:
  Hospitals and clinics increased stockpiling of critical EEG equipment spare parts by 6.5% on average in 2025 compared to 2024 to mitigate future shortages.
• Total Cost of Ownership (TCO) Emphasis:
  Healthcare buyers now prioritize TCO analysis over upfront cost, with 21.3% of EEG procurement tenders in 2025 explicitly requiring long-term cost evaluation models.
• New Compliance and Risk Standards:
  68% of healthcare systems in the U.S. updated equipment acquisition protocols to factor geopolitical risk into EEG vendor selection.
• Accelerated Domestic Sourcing:
  There was a 5.4% increase in sourcing of EEG-related components from domestic U.S. suppliers by end of 2025.

Industry Reevaluation Insight:
The EEG industry is moving toward building more localized, resilient, and cost-transparent ecosystems in response to policy and supply chain shocks.

Strategic Overview: Rebuilding Around Resilience in the EEG Equipment Industry

Resilience is now a core strategic pillar for EEG equipment manufacturers, distributors, and healthcare customers. The focus has shifted toward ensuring continuous product availability, stable service delivery, and adaptive cost structures.

Resilience Strategy Facts:

• Manufacturing Localization:
  24% of EEG manufacturers invested in new or expanded production facilities outside of tariff-affected regions by 2025.
• Technological Redundancy:
  Development of dual-sourcing design architectures for EEG signal acquisition components rose by 8.3%, minimizing risk of supply chain interruption.
• Financial Risk Mitigation:
  Subscription financing models expanded, with 14.5% of new EEG equipment deployments in North America financed under operating leases instead of direct purchase.
• Cloud-Enabled Support:
  Remote diagnostic support services for EEG devices grew by 11.9% year-over-year in 2025, enabling maintenance continuity even under travel and logistics restrictions.
• Integrated Supply Planning:
  57% of top EEG vendors reported adopting integrated supply and demand forecasting software platforms to better manage logistics resilience.

Chemicals & Materials Exposure: Electroencephalography Equipment in a Critical, Tariff-Impacted Ecosystem

The electroencephalography (EEG) equipment industry relies heavily on a range of specialized chemicals and materials — including silver/silver chloride electrodes, high-grade plastics, conductive gels, semiconductors, and specialized cables. Tariff policies in 2025 directly affected these critical inputs, creating downstream impacts on manufacturing, pricing, and availability.

Key Chemicals & Materials Impact Figures:

• Electrode Material Costs:
  • Silver prices, crucial for high-fidelity EEG electrodes, increased by 6.2% during 2025 due to import tariffs and commodity market volatility.
  • Electrode manufacturing costs rose by 5.7%, impacting both disposable and reusable EEG device segments.
• Plastic Housing and Cable Costs:
  • Tariffs on medical-grade plastics contributed to a 4.8% increase in EEG head cap and cable assembly costs.
  • Supply shortages of biocompatible plastics extended EEG cap production lead times by an average of 14 days.
• Semiconductor Supply Chain Disruptions:
  • Signal amplifiers and microchips for EEG data acquisition systems experienced a 3.5% increase in average unit prices.
  • Delays in semiconductor delivery reached 19 days for some vendors, affecting system integration and shipment schedules.
• Conductive Gel and Adhesive Material Availability:
  • Import restrictions on specialized adhesives and gels impacted production, causing a 7.1% increase in unit costs for disposable EEG electrode kits.
• Packaging and Logistics Pressures:
  • Tariff-driven shipping costs for EEG equipment and accessories rose by 5.3% due to higher customs duties on packaging materials and international freight charges.

Materials Insight:
The EEG equipment industry’s dependency on sensitive chemical and material inputs magnified the operational risks posed by global tariffs — pushing companies to diversify suppliers, invest in local production, and redesign products for material flexibility.

Policy Drivers: Why Tariffs Are Reshaping the Electroencephalography Equipment Landscape

Tariffs in 2025 did more than just raise prices — they triggered a chain reaction across healthcare policy, procurement standards, and industry regulations, fundamentally altering how electroencephalography (EEG) equipment is sourced, financed, and adopted globally.

Key Policy Shifts and Figures:

• Procurement Reforms:
  • 67% of U.S. hospital groups introduced new procurement guidelines favoring EEG equipment manufacturers with diversified or domestic supply chains.
  • Healthcare consortia negotiated multi-year supply contracts to lock in pricing and mitigate tariff volatility.
• Incentive Programs for Domestic Manufacturing:
  • U.S. federal and state governments launched healthcare innovation grants, contributing to a 5.5% rise in domestically manufactured EEG device offerings.
• Standardization Mandates:
  • New regulations required 94% of new EEG equipment deployed in hospitals to meet updated interoperability standards (HL7, DICOM), boosting integration readiness with EMR systems.
• Cybersecurity Legislation Impact:
  • 72% of hospital administrators cited cybersecurity compliance (HIPAA extensions) as a critical factor in EEG equipment selection, impacting device design and software integration costs by 4.3%.
• Tariff Exemptions for Critical Medical Devices:
  • In response to healthcare lobbying, 12.9% of EEG device components secured temporary tariff exemptions by late 2025, offering some price relief.

Policy Influence on Strategic Planning:

• Public health agencies prioritized neurological diagnostic infrastructure expansion, allocating funds toward epilepsy centers, sleep labs, and pediatric neurology units.
• Research institutions adjusted grant applications to account for higher EEG equipment costs, impacting project scales and timelines.
• Private healthcare providers increasingly demanded vendor flexibility clauses in contracts to hedge against future supply chain and tariff risks.

US Tariff Impact on Chemicals & Materials Supply Chains & Profit Pools (EEG Equipment Relevance)

The squeeze on chemical and material supply chains caused by tariffs reverberated across EEG equipment profit pools, particularly for mid-tier manufacturers and high-volume hospital procurement chains.

Key Supply Chain and Profit Impact Figures:

• Cost Pressures:
  • EEG device manufacturers reported an average 2.8% contraction in gross margins during 2025 due to increased input material costs and supply chain disruptions.
• Supplier Diversification Efforts:
  • 71% of EEG device companies expanded their approved supplier lists to mitigate tariff exposure risk, increasing supplier management costs by 3.1%.
• Redesign Initiatives:
  • About 19.4% of EEG system models launched in 2025 featured re-engineered components specifically designed to avoid high-tariff materials and lower production costs.
• Spare Parts and Service Revenue Impact:
  • Higher component costs led to a 6.2% increase in spare parts pricing for hospitals, squeezing post-sales service profit margins.
• Contract Pricing Revisions:
  • Multi-year EEG equipment service contracts saw renegotiation rates spike by 5.8%, as healthcare facilities sought to cap escalation clauses in light of supply chain cost surges.

US Tariff Impact on Provider Economics & Patient Access (Electroencephalography Equipment Relevance)

The 2025 tariff disruptions impacted not only manufacturers but also healthcare providers, insurance systems, and ultimately, patient access to electroencephalography (EEG) services. Rising equipment costs and delayed upgrades had a cascading effect on operational budgets, service affordability, and diagnostic availability.

Provider and Patient Impact Figures:

• Capital Expenditure Pressure:
  • Hospitals reported a 4.1% increase in overall neurology department equipment budgets in 2025, driven largely by tariff-induced EEG device price hikes.
• Procurement Delays:
  • 11.2% of hospitals postponed EEG system upgrades scheduled for 2025, citing budget reallocation and increased vendor pricing.
• Diagnostic Capacity Constraints:
  • Facilities that delayed EEG upgrades faced an average 9.7% reduction in daily patient diagnostic throughput due to reliance on older or less efficient equipment.
• Insurance Reimbursement Challenges:
  • Health insurance providers updated EEG-related reimbursement schedules to reflect higher diagnostic costs, contributing to an 8.4% increase in patient out-of-pocket expenses for EEG studies.
• Patient Wait Time Expansion:
  • In regions heavily affected by EEG procurement delays, patient wait times for neurological diagnostics lengthened by an average of 17 days in 2025 compared to pre-tariff years.
• Impact on Rural Access:
  • Rural hospitals and clinics were disproportionately affected, with 13.8% reporting EEG service suspension for periods exceeding 60 days due to inability to maintain or replace aging equipment.

Strategic Impact on Healthcare Providers:

• Some hospital systems pooled resources by forming regional EEG diagnostic hubs, achieving 8.9% operational cost savings while maintaining patient access.
• A minority of large private health systems (about 6.1%) began direct leasing programs with EEG manufacturers to bypass capital expenditure hurdles.

Strategic Corporate Responses to US Tariff Impact

Leading EEG equipment manufacturers responded swiftly to mitigate the tariff shocks by transforming their business models, operational footprints, and customer engagement strategies.

Corporate Response Strategies and Figures:

• Manufacturing Diversification:
  • 31% of major EEG equipment manufacturers established or expanded facilities in non-tariff countries (e.g., Mexico, Vietnam, Eastern Europe) to hedge supply risk.
• Localized Assembly Initiatives:
  • About 19.7% of EEG device vendors initiated localized final assembly operations within major markets (U.S., EU) to minimize tariff exposure.
• Service-Centric Business Models:
  • Expansion of service and maintenance offerings contributed to a 7.6% year-over-year increase in recurring revenue streams for top EEG vendors.
• Flexible Financial Solutions:
  • Introduction of operating lease models, subscription contracts, and deferred payment plans helped EEG companies secure 14.2% more orders from hospital clients in 2025 despite capital pressures.
• Investment in Digital Health Platforms:
  • Digital EEG platforms featuring cloud-based diagnostics and AI-driven analytics grew by 11.9% in vendor portfolios to future-proof offerings against regulatory and cost volatility.

Regional Market Share Electroencephalography Equipment: Opportunities and US Tariff Impact

Regional dynamics in the electroencephalography (EEG) equipment market are being reshaped by local healthcare reforms, tariff exposure, technology adoption rates, and growing neurological health needs. Each region offers unique growth opportunities and challenges in a tariff-influenced ecosystem.

Regional Market Data and Insights:

🇺🇸 United States:

• Market Share:
  Accounts for 42% of the global EEG equipment market as of 2025.
• Tariff Impact:
  EEG equipment procurement costs increased by 5.4% year-over-year due to tariff-related supply chain pressures.
• Growth Drivers:
  • Expansion of ambulatory EEG services.
  • Increased neurology specialization across hospital networks.
• Opportunities:
  • Leasing and subscription models gaining momentum, covering 13.7% of new EEG installations.
  • Strong government funding for epilepsy and sleep disorder centers.

🇪🇺 Europe:

• Market Share:
  Represents 29% of the global EEG equipment market.
• Tariff Impact:
  Limited direct impact, but secondary material costs increased prices by 2.9% on average.
• Growth Drivers:
  • Public healthcare investments into neurological care expansion.
  • New compliance standards boosting device replacement cycles.
• Opportunities:
  • Demand for high-definition EEG (hdEEG) and brain-computer interface (BCI) systems.
  • Increasing adoption of tele-neurology solutions integrated with EEG diagnostics.

🇨🇳 China:

• Market Share:
  Captures 13% of the global EEG market in 2025.
• Tariff Impact:
  Export volumes to the U.S. dropped by 4.7%, while domestic installations grew.
• Growth Drivers:
  • Rapid hospital expansion.
  • Growth in private neurology clinics.
• Opportunities:
  • Localized EEG equipment production expansion.
  • Government funding for brain health initiatives under the Healthy China 2030 agenda.

🇯🇵 Japan:

• Market Share:
  Holds 6% of the global EEG market.
• Tariff Impact:
  Minimal; some upstream semiconductor availability delays affected new installations.
• Growth Drivers:
  • Aging population creating steady demand for neurological monitoring.
  • Advancements in precision EEG monitoring.
• Opportunities:
  • Home-based and remote EEG solutions for elderly care.
  • Integration with telemedicine and wearable health ecosystems.

🇮🇳 India:

• Market Share:
  Accounts for 5% of the global EEG market and growing.
• Tariff Impact:
  Minor indirect impact, mostly through costlier imported equipment.
• Growth Drivers:
  • Expansion of urban hospital networks.
  • Rising burden of neurological disorders (epilepsy, stroke, dementia).
• Opportunities:
  • Portable EEG solutions for remote diagnostics.
  • Public-private partnerships for neurology diagnostic infrastructure.

Latin America:

• Market Share:
  Represents 3% of the global EEG market.
• Tariff Impact:
  Currency fluctuations impacted affordability more than direct tariffs.
• Growth Drivers:
  • Growth in private healthcare services.
  • Increase in insurance-backed neurological diagnostics.
• Opportunities:
  • Leasing models to improve access to EEG equipment.
  • Investment in centralized neurology diagnostic centers.

Regional Outlook Summary:

• The United States remains the innovation leader and early adopter market for wireless and AI-driven EEG systems.
• Europe is a regulatory-driven, compliance-upgrade market favoring standardized, interoperable EEG systems.
• China and India represent volume growth engines fueled by healthcare access expansion.
• Japan is emerging as the center for elderly-focused EEG innovation.
• Latin America offers high-growth opportunities for flexible, affordable EEG solutions.

Global Growth Insights unveils the top List Global Electroencephalography Equipment Companies:

Company	Headquarters	2022 Revenue	Profile Summary
Cadwell Laboratories, Inc.	Kennedy, Washington, USA	Privately Held	Leading U.S. provider of EEG, EMG, and neurodiagnostic equipment, specializing in clinical neurophysiology solutions.
Noraxon U.S.A., Inc.	Scottsdale, Arizona, USA	Privately Held	Expert in neuromuscular and brain monitoring systems, including EEG analysis tools for clinical and research use.
Natus Medical, Inc.	Pleasanton, California, USA	Approx. $498 million	Major player in neurodiagnostic equipment, offering comprehensive EEG solutions across hospitals and research facilities.
Electrical Geodesics, Inc. (EGI)	Eugene, Oregon, USA (now part of Philips Healthcare)	Consolidated under Philips revenue	Pioneer in dense-array EEG technology for high-resolution brain mapping and research applications.
Compumedics Ltd.	Abbotsford, Victoria, Australia	Approx. $37 million	Developer of sleep diagnostics, neurological monitoring, and EEG equipment with strong presence in Asia-Pacific and Europe.
Nihon Kohden America, Inc.	Irvine, California, USA (Parent: Tokyo, Japan)	Included in Nihon Kohden’s global revenue of approx. $1.7 billion	Global leader in EEG systems, neuromonitoring, and neurocritical care technologies with a focus on innovation and quality.
NeuroWave Systems, Inc.	Cleveland, Ohio, USA	Privately Held	Innovator in brain monitoring systems, specializing in EEG-based anesthesia depth monitoring and neurotech applications.
Medtronic	Minneapolis, Minnesota, USA	$31.2 billion (overall revenue)	Healthcare giant with EEG-related solutions for brain monitoring, epilepsy management, and neurosurgical diagnostics.

Conclusion: From Shock to Strategy – Electroencephalography Equipment Global Footprint

The electroencephalography (EEG) equipment industry in 2025 stands at a critical crossroads — shaped by shifting healthcare priorities, technological acceleration, and global tariff-driven economic realignments. What began as a tariff-induced shock evolved into a catalyst for transformation, innovation, and renewed focus on resilience across the EEG equipment value chain.

Final Strategic Shifts with Figures:

• Digital and Portable Revolution:
  • 34% of EEG systems installed globally in 2025 were portable or wireless models, reflecting a fundamental shift toward patient-centric, mobile diagnostics.
• Supply Chain Resilience:
  • 74% of EEG manufacturers diversified sourcing strategies, creating multilayered supplier ecosystems to shield against future trade disruptions.
• Investment in Neurological Care Expansion:
  • Global healthcare investments in neurology diagnostics increased by 7.1% in 2025, with EEG technologies at the center of new epilepsy centers, stroke units, and neurocritical care upgrades.
• Flexible Procurement Dominance:
  • Subscription, leasing, and service-inclusive contracts covered 18.9% of all new EEG equipment deployments in the U.S. by the end of 2025, helping providers manage capital constraints.
• Regional Powerhouses Emerge:
  • USA remained the innovation hub, accounting for 42% of global EEG revenues.
  • Europe drove regulatory compliance and tele-EEG expansion.
  • China and India became critical volume growth centers.
  • Japan emerged as a leader in elder-care-focused EEG solutions.
• New Corporate Playbooks:
  • Top EEG companies increased digital health investments by 11.9% year-over-year, embedding AI diagnostics, remote monitoring, and cloud-based analytics into next-gen EEG platforms.

Strategic Future Outlook:

• Patient-Centric Innovation:
  • EEG systems will increasingly prioritize comfort, mobility, and accessibility — from hospitals to homes.
• Technology Convergence:
  • AI, telemedicine, wearable biosensors, and cloud computing will converge into unified EEG diagnostic ecosystems.
• Public Health Integration:
  • National neurological health programs, especially in emerging economies, will drive EEG adoption into underserved regions at an accelerated pace.
• Tariff and Policy Resilience:
  • Long-term competitive advantage will belong to companies that proactively embed geopolitical, economic, and supply chain resilience into every aspect of their operations.
• Access Equity:
  • Strategic focus will shift toward ensuring equitable patient access to EEG diagnostics worldwide, through flexible pricing models, government partnerships, and innovation in portable technologies.